HAVCR1
Hepatitis A virus cellular receptor 1
Also known as: CD365, HAVCR, HAVCR-1, HAVR1_HUMAN, KIM1, TIM-1, TIM1, TIMD1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96D42
- Gene
- HAVCR1
- Ensembl
- ENSG00000113249
- Chromosome
- 5
- Canonical length
- 364 aa
- Protein class
- CD markers, Predicted membrane proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
The protein encoded by this gene is a membrane receptor for both human hepatitis A virus (HHAV) and TIMD4. The encoded protein may be involved in the moderation of asthma and allergic diseases. The reference genome represents an allele that retains a MTTVP amino acid segment that confers protection against atopy in HHAV seropositive individuals. The protein is a receptor for multiple other viruses, including Ebola virus, Marburg virus, Dengue virus, and Zika virus and is a possible entry factor for SARS-CoV-2 and other coronaviruses. [provided by RefSeq, Sep 2021]
Canonical amino-acid sequenceUniProt
364 residues, UniProt reviewed canonical sequence.
>Q96D42|HAVCR1
1 MHPQVVILSL ILHLADSVAG SVKVGGEAGP SVTLPCHYSG AVTSMCWNRG SCSLFTCQNG
61 IVWTNGTHVT YRKDTRYKLL GDLSRRDVSL TIENTAVSDS GVYCCRVEHR GWFNDMKITV
121 SLEIVPPKVT TTPIVTTVPT VTTVRTSTTV PTTTTVPMTT VPTTTVPTTM SIPTTTTVLT
181 TMTVSTTTSV PTTTSIPTTT SVPVTTTVST FVPPMPLPRQ NHEPVATSPS SPQPAETHPT
241 TLQGAIRREP TSSPLYSYTT DGNDTVTESS DGLWNNNQTQ LFLEHSLLTA NTTKGIYAGV
301 CISVLVLLAL LGVIIAKKYF FKKEVQQLSV SFSSLQIKAL QNAVEKEVQA EDNIYIENSL
361 YATDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HAVCR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 6.5 nTPM
Expression across tissuesHPA
Tissue
- kidney: 6.5 nTPM
- colon: 4.3 nTPM
- rectum: 3.4 nTPM
- testis: 0.9 nTPM
- lymph node: 0.8 nTPM
- bone marrow: 0.7 nTPM
Single-cell type
- proximal tubule cells: 71 nCPM
- loop of henle epithelial cells: 14 nCPM
- nk-cells: 12 nCPM
- colonocytes: 11 nCPM
- cdc: 7.9 nCPM
- macrophages: 7.7 nCPM
Immune cell
- naive CD4 T-cell: 2.5 nTPM
- T-reg: 2 nTPM
- naive CD8 T-cell: 1.6 nTPM
- memory CD4 T-cell: 1 nTPM
- neutrophil: 0.8 nTPM
- basophil: 0.6 nTPM
Brain region
- white matter: 3.8 nTPM
- cerebellum: 3.7 nTPM
- hypothalamus: 3.3 nTPM
- medulla oblongata: 3.3 nTPM
- pons: 3.3 nTPM
- thalamus: 3.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HAVCR1.
Disease | ImmuneIEDB
Conditions an epitope on HAVCR1 was assayed in.
- multiple sclerosis B cell
- amyotrophic lateral sclerosis B cell
- neuromyelitis optica B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.26
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.01
- DepMap mean gene effect
- 0.18
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HAVCR1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HAVCR1 as an antibody target. Whether an autoantibody or antibody against HAVCR1 could matter depends on whether native HAVCR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HAVCR1 is annotated at the cell surface, where native HAVCR1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label HAVCR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...